Winning the right to make a vaccine without fear of legal repercussions is simply a starting point. A company that wants to make vaccines in the developing world also will need specialized training, costly and scarce equipment, and, above all, the transfer of technical know-how from existing patent holders including Pfizer, Moderna, AstraZeneca and Johnson & Johnson.
Source Article from https://www.washingtonpost.com/business/2021/05/06/vaccine-patent-waiver-global-supply/
Comments